Ignite Creation Date:
2024-05-06 @ 12:06 AM
Last Modification Date:
2024-10-26 @ 10:45 AM
Study NCT ID:
NCT01495247
Status:
TERMINATED
Last Update Posted:
2020-12-08
First Post:
2011-09-30
Brief Title:
Phase IbII Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative Locally Advanced or Metastatic Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis